Patent Situation Analysis of Diagnosis Technology for Coronavirus Infection in Human

doi:10.13523/j.cb.2002104

China Biotechnology

2020, Vol. 40

Issue (1-2): 51-56 DOI: 10.13523/j.cb.2002104

Orginal Article

Patent Situation Analysis of Diagnosis Technology for Coronavirus Infection in Human

ZHAO Ping,YANG Yan-ping(

)

National Science Library, Chinese Academy of Sciences, Beijing 100190, China

Download:

HTML

PDF(1039KB) HTML
Export: BibTeX | EndNote (RIS)

Abstract

Since the outbreak of Corona Virus Disease 2019, the speed of diagnosis has been accelerated with the increase of virus detection. This is of great significance for the early treatment and isolation of coronavirus pneumonia patients and the control of the spread of the epidemic. In this paper, based on the patent information for quantitative data analysis, combined with qualitative research, objective display of coronavirus diagnosis technology research and development status. Through the patent application trend, protection market, important patentees, important patents and other dimensions, this paper shows the patent protection profile of coronavirus diagnosis technology, and predicts the future development direction, in order to support the innovation and research of coronavirus diagnosis technology in China.

Key words： Coronavirus Diagnosis Patent

Received: 11 February 2020 Published: 27 March 2020

ZTFLH:

Q819

Corresponding Authors: Yan-ping YANG E-mail: yangyp@mail.las.ac.cn

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Ping ZHAO
	Yan-ping YANG

Cite this article:

ZHAO Ping,YANG Yan-ping. Patent Situation Analysis of Diagnosis Technology for Coronavirus Infection in Human. China Biotechnology, 2020, 40(1-2): 51-56.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2002104 OR https://manu60.magtech.com.cn/biotech/Y2020/V40/I1-2/51

Fig.1 Domestic and foreign patent application trends

Table 1 Major patent publication countries and origin technology countries(TOP 10)

Fig.2 Main technology distribution of coronavirus diagnostic

Fig.3 Main technology patent application trends of coronavirus diagnostic

Fig. 4 Main application areas

Fig.5 Globally important patent applicants

Fig.6 Important patent applicants in China

Table 2 Important Patents


[1]	钱炳旭 . 猪德尔塔冠状病毒抗原及抗体检测方法的建立. 扬州: 扬州大学, 2019.

[1]	Qian B X . Establishment of detection method for antigen and antibody of Porcine Deltacoronavirus. Yangzhou:Yangzhou University, 2019.

[2]	台湾马偕纪念医院. 专利名:一种用以检测严重急性呼吸道症候群冠狀病毒之特异性胜抗原及其方法. 中国台湾, TW092132064.20050516[2020028]. Incopat数据库.

[3]	修乐山 . 基于多重PCR-质谱的冠状病毒高通量检测方法的建立与应用. 北京: 北京协和医学院, 2018.

[3]	Xiu L S . Establishment and Application of High-throughput Detection of Coronavirus Based on Multiplex PCR-Mass Spectrometry. Beijing:Peking Union Medical College, 2018.

[4]	Doan T, Pinsky BA . Current and future molecular diagnostics for ocular infectious diseases. Curr Opin Ophthalmol. 2016,27(6):561-567.

[5]	国家卫生健康委办公厅. 《新型冠状病毒肺炎实验室检测技术指南(第二版)》. [2020028]. http://med.china.com.cn/content/pid/158678/tid/1026.

[6]	庄向婷, 白军, 张振仓 . 新型分子诊断技术在动物疫病检测中的应用与发展. 畜牧与饲料科学, 2018,39(6):108-112.

[6]	Zhuang X T, Bai J, Zhang Z C . Application and Development of New Molecular Diagnostic Techniques in Animal Epidemics Detection. Animal Husbandry and Feed Science, 2018,39(6):108-112.

[7]	吴衍恒, 林金思, 师舞阳 , 等. 应用芯片式数字PCR检测人血清中登革病毒载量. 公共卫生与预防医学, 2019,30(03):16-20.

[7]	Wu Y H, Lin J S, Shi W Y , et al. Detection of dengue virus load in human serum by chip digital PCR. Pub Health and Prev Med, 2019,30(03):16-20.

[8]	BRAY E A . Classification of genes differentially expressed during water-deficit stree in Arabidopsis thaliana: An analysis using microarray and differential expression data. Annals of Botany, 2002,89:803-811.

[9]	郭柯磊, 欧阳昭连, 杜然然 , 等. 国际生物技术专利计量分析. 生物技术通讯, 2011,22(02):248-251.

[9]	Guo K L, Ouyang Z L, Du R R , et al. Study of International Patents on Biotechnology. Letters in Biotechnology 2011,22(02):248-251.

[1]	MA Qiao-ni,WANG Meng,ZHU Xing-quan. Research Advances in Recombinase-aided Amplification Technology and Its Application in Rapid Detection of Pathogenic Microorganisms[J]. China Biotechnology, 2021, 41(6): 45-49.

[2]	CHEN Ying,LI Qian. Patent Analysis on the Development Trend of Industrial Application of Special Yeast[J]. China Biotechnology, 2021, 41(4): 91-99.

[3]	SHI Zhong-lin,CUI Jun-sheng,YANG Ke,HU An-zhong,LI Ya-nan,LIU Yong,DNEG Guo-qing,ZHU Can-can,ZHU Ling. Research Progress in Isothermal Amplification of Nucleic Acid Based on Microfluidic Chip[J]. China Biotechnology, 2021, 41(2/3): 116-128.

[4]	FAN Yue-lei,WANG Yue,WANG Heng-zhe,LI Dan-dan,MAO Kai-yun. *Research Progress of in Vitro* Diagnostic Technologies for SARS-CoV-2**[J]. China Biotechnology, 2021, 41(2/3): 150-161.

[5]	ZHANG Sai,XIANG Le,LI Lin-hai,LI Hui-jun,WANG Gang,QIAN Chun-gen. Development and Performance Evaluation of A Rapid IgM-IgG Combined Antibody Test for 2019 Novel Coronavirus Infection[J]. China Biotechnology, 2020, 40(8): 1-9.

[6]	WU Rui-jun,LI Zhi-fei,ZHANG Xin,PU Run,AO Yi,SUN Yan-rong. Development and Prospect of Antibody Drugs for SARS-CoV-2[J]. China Biotechnology, 2020, 40(5): 1-6.

[7]	JIANG Tian,ZHANG Chao,LIU Hui-zhou. Development Trends Analysis of Microbial Fuel Cell[J]. China Biotechnology, 2020, 40(1-2): 189-197.

[8]	XIE Hua-ling,LV Lu-cheng,YANG Yan-ping. Patent Analysis of Global Coronavirus Vaccine[J]. China Biotechnology, 2020, 40(1-2): 57-64.

[9]	GONG Yue,LIAO Qing-yun,YU Qian-qian,SHI Zhi-xiang,CHEN Jing,ZHANG Yu-hui,ZHAO Guang-hui. A Bibliometric Analysis on Coronaviruses[J]. China Biotechnology, 2020, 40(1-2): 21-37.

[10]	LI Dong-qiao,LV Lu-cheng,YANG Yan-ping. The Research Status and Development Trend of Global Human Coronavirus Antibody Field[J]. China Biotechnology, 2020, 40(1-2): 65-70.

[11]	CHENG Yong-qing,LIU Jin-yi,LIN Fu-Yu,TONG Mei. Novel Coronavirus Control and the Important Contribution of Interferon α1b[J]. China Biotechnology, 2020, 40(1-2): 71-77.

[12]	HUANG Peng-fei,CHEN Yun,LU Jiao,MAO Kai-yun,YUAN Yin-chi. Development Situation and Suggestions of Biomedicine Patent-intensive Industry, Based on the Case Study of Shanghai[J]. China Biotechnology, 2020, 40(12): 108-116.

[13]	WANG Guo-qiang,YU Yin-yin,ZENG Hua-hui,WANG Xu-dong,WU Yu-bin,SHANG Li-zhi,LI Yu-lin,ZHANG Yi-qing,ZHANG Xi-xi,ZHANG Zhen-qiang,WANG Yun-long. Preparation of Quality Control Materials for RT-PCR Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Based on MS2 Phage Virus-like Particles[J]. China Biotechnology, 2020, 40(12): 31-40.

[14]	CHEN Li-jun,QU Jing-jing,XIANG Charlie. Therapeutic Potentials, Clinical Studies, and Application Prospects of Mesenchymal Stem Cells in 2019 Novel Coronavirus (COVID-19)[J]. China Biotechnology, 2020, 40(11): 43-55.

[15]	CHENG Zi-zhao,CHEN Chu-chu,YING Lei,LI Xiao-kun,HUANG Zhi-feng. Comparison of Genomic and Infection Characteristics of Coronavirus[J]. China Biotechnology, 2020, 40(11): 56-66.

Viewed

Full text

Abstract

Cited

Shared

Discussed